Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
نویسندگان
چکیده
منابع مشابه
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients
The potential of the systemic antifungal treatment of non-immunocompromised patients with sepsis, extra-digestive Candida colonization and multiple organ failure is unknown, although it represents three out of four antifungal treatments prescribed in intensive care units. It may allow an early treatment of invasive fungal infection at incubation phase, but exposes patients to unnecessary antifu...
متن کاملCandida infections among neutropenic patients
Background: Systemic candidiasis is a major complication in neutropenic cancer patients undergoing treatment. Most systemic fungal infections emerge from endogenous microflora so the aim of the present study was to identify Candida species isolated from the different regions of body in neutropenic patients in compare with the control group. Methods: A total of 309 neutropenic can...
متن کاملDeterminants of mortality in non-neutropenic ICU patients with candidaemia
INTRODUCTION Candidaemia in critically-ill intensive care unit (ICU) patients is associated with high crude mortality. Determinants of mortality--particularly those amenable to potential modification--are incompletely defined. METHODS A nationwide prospective clinical and microbiological cohort study of all episodes of ICU-acquired candidaemia occurring in non-neutropenic adults was undertake...
متن کاملCandida infections among neutropenic patients
BACKGROUND Systemic candidiasis is a major complication in neutropenic cancer patients undergoing treatment. Most systemic fungal infections emerge from endogenous microflora so the aim of the present study was to identify Candida species isolated from the different regions of body in neutropenic patients in compare with the control group. METHODS A total of 309 neutropenic cancer patients an...
متن کاملEmpiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?
Prior analyses suggest that empiric fluconazole for ICU patients with sepsis is cost-effective. Using updated estimates of efficacy and cost, Zilberberg and colleagues compare the use of micafungin with that of fluconazole. The authors conclude that micafungin is an attractive alternative to fluconazole. This conclusion is driven by recent reduction in micafungin's cost and by better activity o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: F1000Prime Reports
سال: 2015
ISSN: 2051-7599
DOI: 10.12703/p7-21